Dr. Ankit Laddha is a postdoctoral researcher in the Department of Pharmaceutical Sciences at the University of Connecticut, where he investigates mechanisms of drug-induced liver injury, hepatic adaptation, and the regulatory role of transporters such as Mrp4. He earned his Ph.D. in Pharmaceutical Sciences from NMIMS University, India, specializing in understanding molecular mechanism of diabetic complications and studying role of natural products in preventing its progression. Dr. Laddha has authored 33 peer-reviewed publications and 09 book chapter, and serves as a journal reviewer and editorial board member for several pharmacology, toxicology, and molecular sciences journals. His research spans in vivo pharmacology, mechanistic toxicology, transporter biology, inflammation–regeneration balance, and molecular pathway analysis. He has received multiple competitive honors, including the ACT North America Travel Grant, AstraZeneca Innovation in Drug Safety Award, Society of Toxicology Mechanisms Specialty Section Sheldon D. Murphy Postdoctoral Endowment Award, and the NESOT Poster Presentation Award. He was also included in the prestigious Stanford University Top 2% Scientist List, reflecting the global impact of his scientific contributions. Dr. Laddha actively presents his work at national conferences and collaborates across interdisciplinary teams to advance mechanistic insights that support safer and more effective therapeutic development.